Medical Director
Dr. Farheen Shah-Khan M.D. is a board-certified nephrologist at Shifa Nephrology Associates LLC. She has trained at the nation’s finest hospitals and training programs.
Dr. Shah-Khan completed her Nephrology Fellowship from Northwestern Memorial Hospital in Chicago, IL. Dr. Shah-Khan also completed a fellowship in Blood Banking and Transfusion Medicine from the University of Michigan Hospitals in Ann Arbor, MI, and her Internal Medicine Residency Training from Southern Illinois University Hospital.
She started her own practice and had a mission to bring together a group of clinicians who are like-minded and have the passion to serve underserved and neglected populations with Chronic medical conditions like CKD.
Her program features a highly experienced, multidisciplinary team that provides meaningful, hands-on patient care.
The team is dedicated to not just providing supportive care for CKD and ESRD patients but also identifying patients AT RISK for disease progression and preventing the disease progression by using the latest medications in the market.
With a growing number of medications and therapies available to treat chronic kidney disease (CKD), risk-versus-benefit discussions are increasingly critical. Balancing risks and benefits requires assessing patients’ understanding of these, as well as incorporating patient preferences and tolerance for side effects into shared decision-making. Every patient at Shifa Nephrology is assessed and treated with the utmost care, and treatment is tailored according to each patient’s medical condition.
We recommend and guide them with an appropriate diet for CKD patients, in addition to emphasis on daily physical activity and exercise that is needed to maintain muscle mass and nutritional status.
“We have a Dietitian at Shifa Nephrology Associates LLC, a valuable member of the interdisciplinary team and a part of our close-knit collaborative team responsible for delivering unique nutritional care to patients with Chronic Kidney Disease and end-stage renal disease.
In addition to identifying high-risk patients and delaying CKD progression, we also emphasize on Identification and management of its complications like Cardiovascular disease, PVD, Cognitive decline, and bone mineral metabolism to reduce mortality and Morbidity from its consequences.
Our goal is to make a difference in the lives of the patients that we serve.”
